AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

Q: What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in Q1 2014?

67 institutional investors reported FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share for Q1 2014. Use the holders table for investor-level position and value details.

CUSIP: 03152W109

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 314,439,173
Total 13F shares: 34,301,232
Share change: -105,699
Total reported value: $71,016,802
Put/Call ratio: 29%
Price per share: $2.07
Number of holders: 67
Value change: -$323,725
Number of buys: 24
Number of sells: 32

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2014
Previous quarter: Q4 2013

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	2.8%	8,648,087	$20,323,000	—	31 Dec 2013	13F
NEA Management Company, LLC	13F	Company	1.8%	5,653,029	$13,285,000	—	31 Dec 2013	13F
Palo Alto Investors LP	13F	Company	1.3%	4,008,576	$9,420,000	—	31 Dec 2013	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	0.89%	2,797,339	$6,574,000	—	31 Dec 2013	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.78%	2,455,400	$5,770,000	—	31 Dec 2013	13F
VANGUARD GROUP INC	13F	Company	0.38%	1,190,481	$2,798,000	—	31 Dec 2013	13F
BlackRock Fund Advisors	13F	Company	0.26%	830,089	$1,951,000	—	31 Dec 2013	13F
D. E. Shaw & Co., Inc.	13F	Company	0.19%	607,048	$1,426,000	—	31 Dec 2013	13F
SOUND ENERGY PARTNERS, INC.	13F	Company	0.19%	595,200	$1,399,000	—	31 Dec 2013	13F
TFS CAPITAL LLC	13F	Company	0.19%	586,651	$1,379,000	—	31 Dec 2013	13F
FMR LLC	13F	Company	0.18%	562,204	$1,321,000	—	31 Dec 2013	13F
BAKER BROS. ADVISORS LP	13F	Company	0.16%	515,072	$1,210,000	—	31 Dec 2013	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.16%	512,284	$1,204,000	—	31 Dec 2013	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.14%	450,000	$1,058,000	—	31 Dec 2013	13F
STATE STREET CORP	13F	Company	0.14%	427,738	$1,003,000	—	31 Dec 2013	13F
NORTHERN TRUST CORP	13F	Company	0.14%	426,592	$1,003,000	—	31 Dec 2013	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.13%	399,401	$939,000	—	31 Dec 2013	13F
ROYCE & ASSOCIATES LP	13F	Company	0.11%	355,700	$836,000	—	31 Dec 2013	13F
MORGAN STANLEY	13F	Company	0.1%	309,121	$726,000	—	31 Dec 2013	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.09%	277,663	$653,000	—	31 Dec 2013	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.09%	276,465	$650,000	—	31 Dec 2013	13F
Iguana Healthcare Management, LLC	13F	Company	0.08%	265,000	$623,000	—	31 Dec 2013	13F
Healthcare Value Capital, LLC	13F	Company	0.08%	250,000	$588,000	—	31 Dec 2013	13F
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC	13F	Company	0.06%	193,228	$454,000	—	31 Dec 2013	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	155,104	$364,000	—	31 Dec 2013	13F
Bank of New York Mellon Corp	13F	Company	0.05%	151,580	$356,000	—	31 Dec 2013	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	123,481	$290,000	—	31 Dec 2013	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	121,200	$285,000	—	31 Dec 2013	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.04%	116,300	$249,000	—	31 Dec 2013	13F
AXA S.A.	13F	Company	0.03%	94,421	$222,000	—	31 Dec 2013	13F
BlackRock Investment Management, LLC	13F	Company	0.03%	88,750	$209,000	—	31 Dec 2013	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	82,265	$193,000	—	31 Dec 2013	13F
CREDIT SUISSE AG/	13F	Company	0.02%	77,524	$183,000	—	31 Dec 2013	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	55,200	$130,000	—	31 Dec 2013	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	54,764	$129,000	—	31 Dec 2013	13F
P.R. Herzig & Co. Inc.	13F	Company	0.02%	53,000	$125,000	—	31 Dec 2013	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	52,524	$123,000	—	31 Dec 2013	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	45,095	$106,000	—	31 Dec 2013	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.01%	39,690	$93,000	—	31 Dec 2013	13F
NOMURA HOLDINGS INC	13F	Company	0.01%	37,305	$88,000	—	31 Dec 2013	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.01%	37,000	$86,000	—	31 Dec 2013	13F
LMR Master Fund Ltd	13F	Company	0.01%	34,354	$81,000	—	31 Dec 2013	13F
DRW Securities, LLC	13F	Company	0.01%	33,593	$79,000	—	31 Dec 2013	13F
BROWN ADVISORY INC	13F	Company	0.01%	31,850	$75,000	—	31 Dec 2013	13F
CONNOR CLARK & LUNN INVESTMENT MANAGEMENT LTD	13F	Company	0.01%	27,800	$69,000	—	31 Dec 2013	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.01%	28,912	$68,000	—	31 Dec 2013	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	28,706	$67,000	—	31 Dec 2013	13F
Deutsche Girozentrale DekaBank	13F	Individual	0.01%	28,500	$66,000	—	31 Dec 2013	13F
BLACKROCK ADVISORS LLC	13F	Company	0.01%	25,263	$59,000	—	31 Dec 2013	13F
STONERIDGE INVESTMENT PARTNERS LLC	13F	Company	0.01%	25,139	$59,000	—	31 Dec 2013	13F

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q1 2014

As of 31 Mar 2014, AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,301,232 shares. The largest 10 holders included Redmile Group, LLC, NEA Management Company, LLC, Palo Alto Investors, LLC, RS INVESTMENT MANAGEMENT CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, BlackRock Fund Advisors, D. E. Shaw & Co., Inc., and SOUND ENERGY PARTNERS, INC.. This page lists 67 institutional shareholders reporting positions in this security for the Q1 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2014 vs Q4 2013 Across Filers

Q4 2013 holders

Q1 2014 holders

Holder diff

Investor	Q4 2013 Shares	Q1 2014 Shares	Share Diff	Share Chg %	Q4 2013 Value $	Q1 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.